Get the Stockscreener App
0.7994
8.14%
-0.0708
Envveno Medical Corporation stock is traded at $0.7994, with a volume of 2.07M.
It is down -8.14% in the last 24 hours and down -83.65% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.8702
Open:
$0.88
24h Volume:
2.07M
Relative Volume:
3.03
Market Cap:
$15.39M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.3718
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-20.06%
1M Performance:
-83.65%
6M Performance:
-77.35%
1Y Performance:
-84.92%
1-Day Range:
$0.766
$0.89
1-Week Range:
$0.766
$1.03
52-Week Range:
$0.766
$5.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.7994 | 16.75M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
132.66 | 228.64B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.50 | 156.70B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.41 | 148.97B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 117.96B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.34 | 47.69B | 5.69B | 1.41B | 577.90M | 6.95 |
Envveno Medical Corporation Stock (NVNO) Latest News
What to expect from enVVeno Medical Corporation in the next 30 days2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Chart based analysis of enVVeno Medical Corporation trendsPortfolio Profit Report & Expert Verified Movement Alerts - Newser
Advanced analytics toolkit walkthrough for enVVeno Medical CorporationJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
Exit strategy if you’re trapped in enVVeno Medical CorporationPortfolio Growth Summary & Long-Term Investment Growth Plans - Newser
Will earnings trigger a reversal in enVVeno Medical CorporationMarket Volume Report & Detailed Earnings Play Strategies - Newser
Visual analytics tools that track enVVeno Medical Corporation performanceJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - Newser
Can a trend reversal in enVVeno Medical Corporation lead to recovery - Newser
enVVeno Medical Corporation recovery potential after sell offJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
What MACD and RSI say about enVVeno Medical CorporationWeekly Trend Recap & AI Based Buy and Sell Signals - Newser
Why enVVeno Medical Corporation is moving today2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
Is enVVeno Medical Corporation impacted by rising ratesJuly 2025 Market Mood & Risk Controlled Stock Alerts - sundaytimes.kr
Trend analysis for enVVeno Medical Corporation this weekMarket Rally & Community Verified Watchlist Alerts - Newser
enVVeno (NVNO) Plunges 3.75% to Record Low Following FDA Rejection of VenoValve - AInvest
enVVeno Medical Receives FDA Setback for VenoValve - MSN
Is enVVeno Medical Corporation trending in predictive chart modelsFed Meeting & Comprehensive Market Scan Reports - Newser
Signal strength of enVVeno Medical Corporation stock in tech scannersTrade Exit Report & Low Drawdown Trading Strategies - Newser
Understanding enVVeno Medical Corporation’s price movement2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser
Published on: 2025-08-28 19:10:46 - beatles.ru
Volatility clustering patterns for enVVeno Medical CorporationMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):